3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
31
Neoplasms
9
Neoplasm Metastasis
5
Colorectal Neoplasms
3
Wilms Tumor
2
Skin Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Urinary Bladder Neoplasms
1
Thyroid cancer, follicular
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Skin Diseases
1
Pancreatic Neoplasms
1
Neoplasms, Unknown Primary
1
Multiple Myeloma
1
Medulloblastoma
1
Lymphoma
1
Interventions
Cisplatin
9
Cetuximab
6
Radiotherapy, Intensity-Modulated
5
Docetaxel
4
Radiotherapy
3
Fluorouracil
3
Carboplatin
3
pembrolizumab
2
durvalumab
2
Radiation
2
Hydroxyurea
2
Drug Therapy
2
Celecoxib
2
Bupropion
2
130-nm albumin-bound paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
sodium thiosulfate
1
gossypol acetic acid
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Platinum
1
Pilocarpine
1
Oral Hygiene
1
Nicotine Replacement Therapy
1
Nicotine
1
NVP-BKM120
1
Immunoglobulin G
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Laryngeal Neoplasms
×
Vemurafenib
×
Clear all
No trials found.